SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Infinity Pharmaceuticals
INFI 0.0160-4.8%Sep 29 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (15)4/13/2006 10:51:10 AM
From: Steve Lokness  Read Replies (1) of 210
 
Mike;

Thanks. My hat is off to you for seeing this coming. You must have some interest in following Infinity? Since it was private, were you following their science?

As to Biofrontera's library; I was not so much interested in the history, but rather - what now. We know that Infinity did the deal because of the spare cash just sitting there for the picking, but did they see value in the library? I do not have a good feel as to how the acquisition was incorporated into the existing DPII business, but since much of DPII will now be sold, does that include the library?

AND, how fast did this deal develop? The March 6th press release hinted at an IPO and an investment from Novartis. Was this really put together since that date? Wow, maybe. As I see it, they read your post here and THEN the lights went on. <smile> ........Did Infinity feel that the DPII way to go gave them more independence than an IPO and a large Novartis shareholder?

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News